Building access to the Regenstrief Institute is currently restricted. More on our coronavirus precautions.
See our coronavirus precautions.

Regenstrief Institute research scientist Michael “Mick” Murray, PharmD, MPH, is retiring after decades of groundbreaking work. He has been with the institute for 34 years while pioneering in the field of pharmacoepidemiology. He is the Purdue College of Pharmacy Distinguished Professor of Pharmacy Practice and Endowed Chair of Medication Safety.

Dr. Murray began work at Regenstrief in 1986, holding the first Regenstrief-Purdue fellowship in pharmacoepidemiology. He served as the director of the institute’s Health Data & Epidemiology Section from 1996 to 2004 and as the executive director of the institute’s Center for Healthcare Effectiveness Research from 2010 to 2015 while also directing the Regenstrief Data Core (now known as Regenstrief Data Services).

His research focused on improving medication uses and safety in individuals with chronic disease. Dr. Murray developed pharmacy services to improve drug therapy in older adults with chronic disorders and applied pharmacoepidemiology using large population computer databases.

Through more than 130 publications, Dr. Murray substantively advanced the understanding of medication safety, adherence and epidemiology in burdensome medical conditions such as heart failure, hypertension, and dementia.

Dr. Murray is a member of the National Academy of Medicine’s Clinical Effectiveness Research Innovation Collaborative and the World Health Organization’s Committee for Global Patient Safety Challenge on Medication Safety. He has served on the boards of the American Society for Clinical Pharmacology & Therapeutics, the International Society for Pharmacoepidemiology (in which he is a fellow and charter member), and the United States Pharmacopeia. He has won countless awards, including Indiana Public Health Foundation’s Excellence in Health Science Research Award and John M. Eisenberg Memorial Lectureship on Therapeutics Research from the Agency for Health Care Research and Quality.

MEDIA CONTACTS:
John Erickson
Regenstrief Institute
prteam@regenstrief.org
(317) 643-2313
Cindy Fox Aisen
Regenstrief Institute
caisen@regenstrief.org
(317) 843-2275

Related News

Jan 26, 2022 • News
AI models can predict individual risk of hospitalization for COVID using HIE data
Regenstrief study demonstrates how clinical data from healthcare systems can be used to better inform public health decision-making The COVID-19 pandemic has highlighted both the necessity and the difficulty of using clinical data to inform state and national public health policymaking. In a new study, Regenstrief Institute and Indiana University researchers demonstrate that machine learning…
Continue Reading >
Jan 24, 2022 • News
Local mask policy matters when it comes to public health
Findings from a new study show impact of mask mandates on behavior  Local mask policies are strong influencers on mask-wearing behavior, according to new research from Regenstrief Institute, Indiana University Richard M. Fairbanks School of Public Health and Resolve to Save Lives.   Policies requiring face masks in public have been one strategy to address the…
Continue Reading >